A detailed history of Great Diamond Partners, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Great Diamond Partners, LLC holds 4,871 shares of AZN stock, worth $366,396. This represents 0.1% of its overall portfolio holdings.

Number of Shares
4,871
Previous 6,362 23.44%
Holding current value
$366,396
Previous $496,000 23.59%
% of portfolio
0.1%
Previous 0.12%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$76.67 - $87.62 $114,314 - $130,641
-1,491 Reduced 23.44%
4,871 $379,000
Q2 2024

Jul 29, 2024

SELL
$66.81 - $80.83 $30,732 - $37,181
-460 Reduced 6.74%
6,362 $496,000
Q1 2024

May 08, 2024

SELL
$61.03 - $69.57 $12,206 - $13,913
-200 Reduced 2.85%
6,822 $462,000
Q4 2023

Feb 07, 2024

SELL
$61.89 - $69.28 $40,847 - $45,724
-660 Reduced 8.59%
7,022 $472,000
Q3 2023

Oct 19, 2023

SELL
$64.85 - $71.7 $39,558 - $43,737
-610 Reduced 7.36%
7,682 $520,000
Q2 2023

Jul 17, 2023

SELL
$69.91 - $75.81 $7,410 - $8,035
-106 Reduced 1.26%
8,292 $593,000
Q1 2023

May 04, 2023

BUY
$63.15 - $71.6 $4,231 - $4,797
67 Added 0.8%
8,398 $582,000
Q4 2022

Feb 01, 2023

SELL
$54.21 - $70.44 $1,192 - $1,549
-22 Reduced 0.26%
8,331 $564,000
Q3 2022

Oct 24, 2022

BUY
$53.02 - $135.75 $5,832 - $14,932
110 Added 1.33%
8,353 $458,000
Q2 2022

Jul 26, 2022

BUY
$59.26 - $71.14 $111,586 - $133,956
1,883 Added 29.61%
8,243 $544,000
Q1 2022

May 05, 2022

BUY
$55.72 - $67.12 $57,670 - $69,469
1,035 Added 19.44%
6,360 $421,000
Q4 2021

Jan 26, 2022

BUY
$54.02 - $63.83 $26,199 - $30,957
485 Added 10.02%
5,325 $310,000
Q3 2021

Oct 21, 2021

BUY
$55.56 - $60.79 $5,944 - $6,504
107 Added 2.26%
4,840 $290,000
Q2 2021

Jul 26, 2021

BUY
$48.42 - $60.18 $13,702 - $17,030
283 Added 6.36%
4,733 $283,000
Q1 2021

May 04, 2021

BUY
$47.16 - $54.44 $9,432 - $10,888
200 Added 4.71%
4,450 $221,000
Q4 2020

Jan 26, 2021

SELL
$48.52 - $58.02 $74,381 - $88,944
-1,533 Reduced 26.51%
4,250 $212,000
Q3 2020

Oct 19, 2020

SELL
$53.07 - $61.1 $18,680 - $21,507
-352 Reduced 5.74%
5,783 $316,000
Q2 2020

Aug 04, 2020

SELL
$43.1 - $55.31 $6,637 - $8,517
-154 Reduced 2.45%
6,135 $324,000
Q1 2020

May 01, 2020

BUY
$37.79 - $51.33 $146,511 - $199,006
3,877 Added 160.74%
6,289 $280,000
Q4 2019

Feb 07, 2020

BUY
$42.46 - $50.46 $102,413 - $121,709
2,412 New
2,412 $120,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $233B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Great Diamond Partners, LLC Portfolio

Follow Great Diamond Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Diamond Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Diamond Partners, LLC with notifications on news.